Smad3 Sensitizes Hepatocelluar Carcinoma Cells to Cisplatin by Repressing Phosphorylation of AKT. [electronic resource]
Producer: 20170215ISSN:- 1422-0067
- Animals
- Antineoplastic Agents -- pharmacology
- Apoptosis -- drug effects
- Carcinoma, Hepatocellular -- drug therapy
- Cell Line, Tumor
- Chromones -- pharmacology
- Cisplatin -- pharmacology
- Cyclin-Dependent Kinase Inhibitor p21 -- metabolism
- Drug Resistance, Neoplasm -- drug effects
- Humans
- Liver Neoplasms -- drug therapy
- Male
- Mice
- Mice, Inbred BALB C
- Mice, Nude
- Morpholines -- pharmacology
- Phosphatidylinositol 3-Kinases -- metabolism
- Phosphorylation -- drug effects
- Proto-Oncogene Proteins c-akt -- metabolism
- Proto-Oncogene Proteins c-bcl-2 -- metabolism
- Proto-Oncogene Proteins c-myc -- metabolism
- Signal Transduction -- drug effects
- Smad3 Protein -- metabolism
- Transplantation, Heterologous
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.